Farzin Farzaneh MSc, PhD, FRCPath, FRSB

Farzin Farzaneh, Ph.D., FRCPath, FRSB, is the Chief Scientific Officer of ViroCell Biologics and serves as a member of the Board of Directors. He is also Chair of Molecular Medicine at King’s College London and Trans-campus Professor of Molecular Medicine at Technical University of Dresden, Germany. He established the Rayne Cell and Gene Therapy Suite for the GMP manufacture of Investigational Medicinal Products and Advanced Therapy Medicinal Products (ATMP) at King’s in 2001. This facility has produced the largest number of viral vectors for gene therapy-based clinical studies in Europe. He is also a Member of the MHRA Commission on Human Medicines: Clinical Trials, Biologicals & Vaccines Expert Advisory Group.